Compressive Dressing and Pharyngocutaneous Fistula After Primary Total Laryngectomy (TIGHT)
Impact of Compressive Dressing on the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Multicenter Retrospective Observational Study
Pharyngocutaneous fistula (PCF) is one of the most feared complications after total laryngectomy. A compressive neck dressing is often applied after surgery to try to prevent it, but there is no consensus on whether it works or how long it should be kept, and practice varies widely between centers. This multicenter, retrospective, observational study compares the rate of PCF in adult patients with laryngeal squamous cell carcinoma who underwent primary total laryngectomy with direct closure of the hypopharyngeal mucosa and who did or did not receive a postoperative compressive dressing. It also examines whether the duration of the dressing affects the risk of fistula and how fistulas were managed in the two groups. All data are collected from existing medical records; no additional treatment or examination is performed.
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Description détaillée
PCF occurs in about 14% of primary total laryngectomies and about 28% of salvage procedures. It is associated with prolonged hospital stay, higher costs, delayed adjuvant treatment, and further complications. No study has directly compared patients managed with and without a postoperative compressive dressing.
This is a non-profit, multicenter, national, retrospective observational study coordinated by IRCCS Azienda Ospedaliero-Universitaria di Bologna. Consecutive patients who underwent primary total laryngectomy from January 1, 2014 to the study start date are included. All patients were treated according to routine clinical practice at each center. Patients are divided into two groups according to postoperative management: compressive dressing of the cervical region over the neopharyngeal suture (Group A) or no compressive dressing (Group B).
Data are extracted from medical records and entered in pseudonymized form in an electronic case report form (REDCap). Collected variables include demographics, smoking and alcohol use, comorbidities, preoperative laboratory values and inflammatory indices, tumor site and clinical stage, surgical details (neck dissection, thyroidectomy, pharyngeal closure technique, salivary stent, primary voice prosthesis), postoperative antibiotic protocol, time to oral feeding, and fistula characteristics and management.
The planned sample size is 950 patients (475 per group), which provides 80% power to detect a 6.0% difference in fistula rate between groups, assuming a baseline rate of 14.3% in the group without compressive dressing, using a two-sided Fisher's exact test with alpha 0.05. The primary outcome will be analyzed with Fisher's exact test. Secondary outcomes will be analyzed with logistic and linear regression. Confounding will be addressed with propensity score matching, inverse probability weighting, or covariate adjustment, as appropriate.
Type d'étude
Type d'étude
Inscription (Estimé)
Inscription
Contacts et emplacements
Coordonnées de l'étude
Coordonnées de l'étude
- Nom: Edoardo Serafini, MD, Medical Degree
- Numéro de téléphone: +39 051 2145263
- E-mail: edoardo.serafini3@unibo.it
Lieux d'étude
-
-
-
Bergamo, Italie
- Recrutement
- ASST Papa Giovanni XXIII
-
Contact:
- Giovanni Danesi, Medical Degree
- Numéro de téléphone: +39 035 2674398
- E-mail: gdanesi@asst-pg23.it
-
Bologna, Italie
- Recrutement
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola
-
Contact:
- Edoardo Serafini, Medical Degree
- Numéro de téléphone: +39 051 2145263
-
Bologna, Italie
- Recrutement
- Ospedale Maggiore Carlo Alberto Pizzardi
-
Contact:
- Luca Amorosa, Medical Degree
- Numéro de téléphone: +39 051 6478365
- E-mail: luca.amorosa@ausl.bologna.it
-
Bolzano, Italie
- Recrutement
- Ospedale Centrale di Bolzano
-
Contact:
- Luca Calabrese, medical degree
- Numéro de téléphone: +39 0471 438641
- E-mail: orlbz@sabes.it
-
Brescia, Italie
- Recrutement
- ASST degli Spedali Civili di Brescia
-
Contact:
- Cesare Piazza, Medical Degree
- Numéro de téléphone: +39 030 3995319
- E-mail: cesare.piazza@unibs.it
-
Candiolo, Italie
- Recrutement
- IRCCS Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia
-
Contact:
- Stefano Bondi, Medical Degree
- Numéro de téléphone: +39 011 9933405
- E-mail: stefano.bondi@ircc.it
-
Cesena, Italie
- Recrutement
- Ospedale M. Bufalini
-
Contact:
- Massimo Magnani, Medical Degree
- Numéro de téléphone: +39 0541 933458
- E-mail: massimo.magnani@auslromagna.it
-
Florence, Italie
- Recrutement
- Azienda Ospedaliero-Universitaria Careggi
-
Contact:
- Giandomenico Maggiore, Medical Degree
- Numéro de téléphone: +39 055 7942000
-
Forlì, Italie
- Recrutement
- Ospedale G.B. Morgagni - L. Pierantoni
-
Contact:
- Andrea De Vito, Medical Degree
- Numéro de téléphone: +39 0543 73651
- E-mail: andrea.devito@auslromagna.it
-
Milan, Italie
- Recrutement
- Istituto Nazionale dei Tumori
-
Contact:
- Alberto Deganello, Medical Degree
- E-mail: alberto.deganello@unimi.it
-
Milan, Italie
- Recrutement
- Ospedale San Raffaele
-
Contact:
- Andrea Galli
- Numéro de téléphone: +390226438446
- E-mail: salerno.emilio@hsr.it
-
Contact:
- Mario Bussi, medical degree
- E-mail: bussi.mario@hsr.it
-
Modena, Italie
- Recrutement
- Azienda Ospedaliero-Universitaria Policlinico di Modena
-
Contact:
- Daniele Marchioni, Medical Degree
- Numéro de téléphone: +39 059 4222402
- E-mail: daniele.marchioni@unimore.it
-
Naples, Italie
- Recrutement
- AORN Ospedale Cardarelli
-
Contact:
- FIlippo Ricciardelli, Medical Degree
- Numéro de téléphone: +39 081 7474035
- E-mail: filippo.ricciardiello@aocardarelli.it
-
Padova, Italie
- Recrutement
- Azienda Ospedale-Università di Padova
-
Contact:
- Piero Nicolai, Medical Degree
- Numéro de téléphone: +39 049 8212024
- E-mail: piero.nicolai@unipd.it
-
Pavia, Italie
- Recrutement
- Fondazione IRCCS Policlinico San Matteo
-
Contact:
- Marco Benazzo, Medical Degree
- E-mail: marco.benazzo@unipv.it
-
Pescara, Italie
- Recrutement
- Ospedale Santo Spirito
-
Contact:
- Claudio D Caporale, Medical Degree
- Numéro de téléphone: +39 085 4252682
- E-mail: claudiodonadio.caporale@asl.pe.it
-
Ravenna, Italie
- Recrutement
- Ospedale Santa Maria delle Croci
-
Contact:
- Ignacio J Fernandez, Medical Degree
- E-mail: ignacio.fernandez4@unibo.it
-
Reggio Emilia, Italie
- Recrutement
- Arcispedale Santa Maria Nuova
-
Contact:
- Angelo Ghidini, Medical Degree
- Numéro de téléphone: +39 0522 296111
- E-mail: angelo.ghidini@ausl.re.it
-
Rimini, Italie
- Recrutement
- Ospedale Infermi
-
Contact:
- Marco Trebbi, Medical Degree
- E-mail: marco.trebbi@auslromagna.it
-
Roma, Italie
- Recrutement
- Fondazione Policlinico Universitario Agostino Gemelli
-
Contact:
- Gaetano Paludetti, Medical Degree
- E-mail: gaetano.paludetti@policlinicogemelli.it
-
Roma, Italie
- Recrutement
- Ospedale Fatebenefratelli Isola Tiberina - Gemelli Isola
-
Contact:
- Marco Radici, Medical Degree
- Numéro de téléphone: +39 06 6837297
- E-mail: marco.radici@fondazionefatebenefratelli.it
-
Roma, Italie
- Recrutement
- Policlinico Umberto I (Sapienza)
-
Contact:
- Marco De Vincentis, Medical Degree
- E-mail: marco.devincentiis@uniroma1.it
-
Torino, Italie
- Recrutement
- AOU Città della Salute e della Scienza (Molinette)
-
Contact:
- Giancarlo Pecorari, Medical Degree
- Numéro de téléphone: +39 011 6709583
- E-mail: giancarlo.pecorari@unito.it
-
Trieste, Italie
- Recrutement
- Ospedale di Cattinara
-
Contact:
- Giancarlo Tirelli, Medical Degree
- Numéro de téléphone: +39 040 3994933
- E-mail: tirellig@units.it
-
Verona, Italie
- Recrutement
- Azienda Ospedaliera Universitaria Integrata di Verona
-
Contact:
- Luca Sacchetto, Medical Degree
- Numéro de téléphone: +39 045 8127538
- E-mail: luca.sacchetto@univr.it
-
Vittorio Veneto, Italie
- Recrutement
- Ospedale di Vittorio Veneto - ULSS 2 Marca Trevigiana
-
Contact:
- Andy Bertolin, Medical Degree
- Numéro de téléphone: +39 0438 665231
- E-mail: andy.bertolin@aulss2.veneto.it
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Consecutive adult patients with squamous cell carcinoma of the larynx who underwent primary total laryngectomy with direct closure of the hypopharyngeal mucosa at the participating Italian otolaryngology centers from January 1, 2014 to the study start date.
La description
Inclusion Criteria:
- Squamous cell carcinoma of the larynx treated with primary total laryngectomy
- Primary closure of the hypopharyngeal mucosa
- Age 18 years or older
- Informed consent to study participation and to personal data processing
- Availability of data on comorbidities, laboratory parameters, and postoperative management
Exclusion Criteria:
- Salvage total laryngectomy
- Previous radiotherapy or chemoradiotherapy to the head and neck
- Previous open surgery of the pharyngolaryngeal region
- Reconstruction with a free or pedicled flap (inlay or onlay)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: RETROSPECTIVE
Nombre de groupes / cohortes
Cohortes et interventions
Groupe / CohorteGroupe / Cohorte |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Compressive dressing (Group A)
Patients who received a postoperative compressive dressing of the cervical region over the neopharyngeal suture after primary total laryngectomy, according to routine clinical practice at the treating center. |
Postoperative compressive dressing applied to the cervical region over the neopharyngeal suture. This is an exposure observed in routine clinical practice; it is not assigned by the study. |
|
No compressive dressing (Group B)
Patients who did not receive a postoperative compressive dressing after primary total laryngectomy, according to routine clinical practice at the treating center. |
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Incidence of pharyngocutaneous fistula
Délai: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients who develop a pharyngocutaneous fistula in each group (compressive dressing vs no compressive dressing). |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Incidence of pharyngocutaneous fistula by duration of compressive dressing
Délai: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients in Group A who develop a pharyngocutaneous fistula, stratified by duration of the compressive dressing (days). |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Time to onset of pharyngocutaneous fistula
Délai: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number of days from surgery to diagnosis of pharyngocutaneous fistula in each group. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Type of management of pharyngocutaneous fistula
Délai: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients with fistula managed conservatively (compressive dressing) or surgically in each group. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Resolution of pharyngocutaneous fistula
Délai: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients whose fistula resolved, by initial group and type of management. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Time to resolution of pharyngocutaneous fistula
Délai: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number of days from diagnosis to resolution of the fistula, by initial group and type of management. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Les enquêteurs
Les enquêteurs
- Chercheur principal: Edoardo Serafini, Medical Degree, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Début de l'étude
Achèvement primaire (Estimé)
Achèvement primaire
Achèvement de l'étude (Estimé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Processus pathologiques
- Tumeurs par site
- Tumeurs
- Maladies des voies respiratoires
- Tumeurs par type histologique
- Tumeurs de la tête et du cou
- Tumeurs, glandulaires et épithéliales
- Tumeurs des voies respiratoires
- Carcinome
- Maladies oto-rhino-laryngologiques
- Tumeurs oto-rhino-laryngologiques
- Carcinome épidermoïde
- Maladies laryngées
- Conditions pathologiques, signes et symptômes
- Carcinome épidermoïde de la tête et du cou
- Tumeurs laryngées
- Complications postopératoires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- 162/2025/Oss/AOUBo
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
De-identified individual participant data underlying the published results will be made available upon reasonable request to the Principal Investigator.
Délai de partage IPD
After publication of the study results in a peer-reviewed journal.
Critères d'accès au partage IPD
Data will be shared with researchers who submit a motivated request to the Principal Investigator of the coordinating center (IRCCS Azienda Ospedaliero-Universitaria di Bologna).
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .